Trial Profile
A Clinical Trial of Mirabegron for Overactive Bladder Symptoms in Patients With Parkinson Disease and Impaired Cognition
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 17 Oct 2018 Status changed from recruiting to completed.
- 08 Nov 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Jun 2018.
- 25 Oct 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.